The report offers detailed coverage of PET Radiopharmaceuticals industry and main market trends.
The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading PET Radiopharmaceuticals by geography. The report splits the market size, by volume and value, on the basis of application type and geography.
The report forecast global PET Radiopharmaceuticals market to grow to reach xxx Million USD in 2020 with a CAGR of xx% during the period 2021-2026.
Note – In order to provide more accurate market forecast, all our reports will be updated before delivery by considering the impact of COVID-19.
First, this report covers the present status and the future prospects of the global PET Radiopharmaceuticals market for 2015-2026.
In this report, we analyze global market from 5 geographies: Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia], Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland], North America[United States, Canada, Mexico], Middle East & Africa[GCC, North Africa, South Africa], South America[Brazil, Argentina, Columbia, Chile, Peru].
Key Companies
Cardinal Health Inc. (U.S.)
Mallinckrodt plc (Ireland)
GE Healthcare (U.K.)
Lantheus Medical Imaging, Inc. (U.S.)
Bayer AG (Germany)
Bracco Imaging S.p.A (Italy)
Eczacibasi-Monrol Nuclear Products (Turkey)
Nordion, Inc. (Canada)
Advanced Accelerator Applications S.A. (France)
IBA Molecular Imaging (Belgium)
At the same time, we classify PET Radiopharmaceuticals according to the type, application by geography. More importantly, the report includes major countries market based on the type and application.
Market by Order Type
F-18
Ru-82
Others
Market by Application
Oncology
Cardiology
Neurology
Others
Market Segment as follows:
By Region
Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia]
Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
North America[United States, Canada, Mexico]
Middle East & Africa[GCC, North Africa, South Africa]
South America[Brazil, Argentina, Columbia, Chile, Peru]
The research provides answers to the following key questions:
• What is the estimated growth rate and market share and size of the PET Radiopharmaceuticals market for the forecast period 2021 - 2026?
• What are the driving forces in the PET Radiopharmaceuticals market for the forecast period 2021 - 2026?
• Who are the prominent market players and how have they gained a competitive edge over other competitors?
• What are the market trends influencing the progress of the PET Radiopharmaceuticals industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the market hold for the prominent market players?
For any other requirements, please feel free to contact us and we will provide you customized report.